{"id":37040,"date":"2026-04-24T10:50:35","date_gmt":"2026-04-24T08:50:35","guid":{"rendered":"https:\/\/kymos.com\/?page_id=37040"},"modified":"2026-04-24T10:51:21","modified_gmt":"2026-04-24T08:51:21","slug":"bioanalyse-des-petites-molecules-et-des-generiques-2","status":"publish","type":"page","link":"https:\/\/kymos.com\/fr\/services\/services-precliniques-et-cliniques\/bioanalyse-des-petites-molecules-et-des-generiques-2\/","title":{"rendered":"Bioanalyse des petites mol\u00e9cules et des g\u00e9n\u00e9riques"},"content":{"rendered":"

Bioanalysis of Small Molecules & Generics<\/h1><\/div>

GLP-certified & GCP-compliant bioanalysis for preclinical, clinical, and bioequivalence studies<\/p>\n<\/div>

Talk to an expert<\/span><\/i><\/a><\/div><\/div><\/div><\/div><\/div>

Kymos Group specializes in world-class bioanalysis of small molecules, offering a comprehensive range of services from fast in vivo and in vitro ADMET screenings to pre-clinical toxicokinetics, bioavailability and pharmacokinetic studies, drug-drug interaction studies, and clinical trials including first-in-man and dose escalation studies.<\/p>\n

Our bioanalysis experts are experienced in comprehensively managing pre-clinical and clinical bioanalysis of small molecules from phases I to IV and bioequivalences for generics. We are a GLP-certified and GCP-compliant multinational CRO with broad experience catering to various client profiles, including:<\/p>\n<\/div>